Publications
By Year
Now showing items 4921-4940 of 5385 records
Differential effects of NOX4 and NOX1 on immune cell-mediated inflammation in the aortic sinus of diabetic ApoE-/- mice
Kennedy, K; Cooper, ME; Jandeleit-Dahm, KA; Chew, P; Gray, SP; Schmidt, HH; Di Marco, E
CLIN SCI - 01 Aug 2016
Oxidative stress and inflammation are central mediators of atherosclerosis particularly in the context of diabetes. The potential interactions between the major producers of vascular reactive oxygen species (ROS), NADPH oxidase (NOX) enzymes and immune-inflammatory processes remain to be fully elucidated. In the present study we investigated the roles of the NADPH oxidase subunit isoforms, NOX4...
Splenic release of platelets contributes to increased circulating platelet size and inflammation after myocardial infarction
Su, Y; Du, XJ; Tsai, A; Moore, XL; Dart, AM; Han, LP; Zhang, M; Xu, Q; Wang, XY; Liu, Y; Gao, XM; Gao, W; Lambert, GW; Kiriazis, H
CLIN SCI - 01 Jul 2016
Acute myocardial infarction (AMI) is characterized by a rapid increase in circulating platelet size but the mechanism for this is unclear. Large platelets are hyperactive and associated with adverse clinical outcomes. We determined mean platelet volume (MPV) and platelet-monocyte conjugation (PMC) using blood samples from patients, and blood and the spleen from mice with AMI. We further measure...
A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy
Meyer, CJ; Lee, JY; Wilkinson-Berka, JL; Petratos, S; de Haan, JB; Deliyanti, D; Ward, KW
CLIN SCI - 01 Aug 2016
An imbalance in oxidative stress and antioxidant defense mechanisms contributes to the development of ischaemic retinopathies such as diabetic retinopathy and retinopathy of prematurity (ROP). Currently, the therapeutic utility of targeting key transcription factors to restore this imbalance remains to be determined. We postulated that dh404, an activator of nuclear factor erythroid-2 related f...
Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes
Nguyen, TV; Penfold, SA; Higgins, GC; Tan, SM; Coughlan, MT; Cooper, ME; Trounce, IA; Thallas-Bonke, V; Thorburn, DR; Forbes, JM; Van Bergen, NJ; Sourris, KC; Harcourt, BE
CLIN SCI - 01 May 2016
Oxidative phosphorylation (OXPHOS) drives ATP production by mitochondria, which are dynamic organelles, constantly fusing and dividing to maintain kidney homoeostasis. In diabetic kidney disease (DKD), mitochondria appear dysfunctional, but the temporal development of diabetes-induced adaptations in mitochondrial structure and bioenergetics have not been previously documented. In the present st...
miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7
Winbanks, CE; Herman-Edelstein, M; Hagiwara, S; McClelland, AD; Cooper, ME; Kantharidis, P; Jha, JC; Komers, R; Gregorevic, P
CLIN SCI - 01 Dec 2015
The cytokine transforming growth factor (TGF)-β1 plays a central role in diabetic nephropathy (DN) with data implicating the miRNA (miR) miR-21 as a key modulator of its prosclerotic actions. In the present study, we demonstrate data indicating that miR-21 up-regulation positively correlates with the severity of fibrosis and rate of decline in renal function in human DN. Furthermore, concomitan...
Breaking up of prolonged sitting over three days sustains, but does not enhance, lowering of postprandial plasma glucose and insulin in overweight and obese adults
Larsen, RN; Hammond, L; Shaw, JE; Dunstan, DW; Cerin, E; Hamilton, MT; Healy, GN; Robinson, C; Kingwell, BA; Owen, N
CLIN SCI - 01 Jul 2015
To compare the cumulative (3-day) effect of prolonged sitting on metabolic responses during a mixed meal tolerance test (MTT), with sitting that is regularly interrupted with brief bouts of light-intensity walking. Overweight/obese adults (n=19) were recruited for a randomized, 3-day, outpatient, cross-over trial involving: (1) 7-h days of uninterrupted sitting (SIT); and (2) 7-h days of sittin...
Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance
Kemp-Harper, BK; Jefferis, AM; Lumsden, NG; Chin-Dusting, JP; Andrews, KL; Farry, J
CLIN SCI - 01 Jul 2015
Pre-clinical studies have identified nitroxyl (HNO), the reduced congener of nitric oxide (NO•), as a potent vasodilator which is resistant to tolerance development. The present study explores the efficacy of HNO in human blood vessels and describes, for the first time, a vasodilator for humans that is not susceptible to tolerance. Human radial arteries and saphenous veins were obtained from pa...
Short-term dietary salt supplementation blunts telmisartan induced increases in plasma renin activity in hypertensive patients with type 2 diabetes mellitus
Thomas, G; Jerums, G; Lambert, E; Baqar, S; Ekinci, EI; O'Callaghan, C; MacIsaac, RJ; Chen, AX; Somarajah, G
CLIN SCI - 01 Sep 2015
Current guidelines recommend low dietary salt intake (LDS) in patients with diabetes to reduce blood pressure (BP). However, low salt intake has been associated with higher mortality rates in people with diabetes. Our aim is to examine the effect of angiotensin II receptor blocker (ARB), telmisartan, with and without dietary sodium chloride (NaCl) supplementation, on BP [mean arterial pressure ...
Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis
Koulis, C; Cooper, ME; Murphy, AJ; Tsorotes, D; Pickering, RJ; Allen, TJ; Jandeleit-Dahm, KA; Gray, SP; Thomas, MC; Kanellakis, P
CLIN SCI - 01 Oct 2014
RAGE (receptor for advanced glycation end-products) is expressed on multiple cell types implicated in the progression of atherosclerosis and plays a role in DAA (diabetes-associated atherosclerosis). The aim of the present study was to determine the relative role of either BM (bone marrow)- or non-BM-derived RAGE in the pathogenesis of STZ (streptozotocin)-induced DAA. Male ApoE (apolipoprotein...
Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes
Tikellis, C; Ahola, A; Harjutsalo, V; Cooper, ME; Saraheimo, M; Tsorotes, D; Pickering, RJ; Wadén, J; Moran, J; Thorn, L; Forsblom, C; Groop, PH; Thomas, MC; Tolonen, N; Gordin, D
CLIN SCI - 01 May 2013
It is recommended that individuals with diabetes restrict their dietary sodium intake. However, although salt intake is correlated with BP (blood pressure), it also partly determines the activation state of the RAAS (renin-angiotensin-aldosterone system), a key mediator of diabetes-associated atherosclerosis. apoE KO (apolipoprotein E knockout) mice were allocated for the induction of diabetes ...
Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of type 2 diabetes
Montezano, AC; Szyndralewiez, C; Hebert, RL; Cooper, ME; Burger, D; Jandeleit-Dahm, K; Burns, KD; Kennedy, CR; Gutsol, A; Nguyen Dinh Cat, A; Page, P; Heitz, F; Touyz, RM; Sedeek, M
CLIN SCI - 01 Feb 2013
Nox (NADPH oxidase)-derived ROS (reactive oxygen species) have been implicated in the development of diabetic nephropathy. Of the Nox isoforms in the kidney, Nox4 is important because of its renal abundance. In the present study, we tested the hypothesis that GKT136901, a Nox1/4 inhibitor, prevents the development of nephropathy in db/db (diabetic) mice. Six groups of male mice (8-week-old) wer...
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation
Tikellis, C; Cooper, ME; Candido, R; Fabris, B; Zauli, G; Bernardi, S; Secchiero, P; Thomas, MC
CLIN SCI - 01 Nov 2012
TRAIL [TNF (tumour necrosis factor)-related apoptosis-inducing ligand] has recently been shown to ameliorate the natural history of DM (diabetes mellitus). It has not been determined yet whether systemic TRAIL delivery would prevent the metabolic abnormalities due to an HFD [HF (high-fat) diet]. For this purpose, 27 male C57bl6 mice aged 8 weeks were randomly fed on a standard diet, HFD or HFD+...
Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes
Nguyen-Huu, TP; Tikellis, C; Pickering, R; Du, XJ; Cooper, ME; Tsorotes, D; Head, GA; Thomas, MC; Kiriazis, H
CLIN SCI - 01 Oct 2012
Local and systemic AngII (angiotensin II) levels are regulated by ACE2 (angiotensin-converting enzyme 2), which is reduced in diabetic tissues. In the present study, we examine the effect of ACE2 deficiency on the early cardiac and vascular changes associated with experimental diabetes. Streptozotocin diabetes was induced in male C57BL6 mice and Ace2-KO (knockout) mice, and markers of RAS (reni...
Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7)
Toffoli, B; Johnston, C; Tikellis, C; Velkoska, E; Pickering, R; Tsorotes, D; Sakoda, M; Burns, WC; Fabris, B; Grixti, E; Bernardi, S; Burrell, LM; Thomas, MC
CLIN SCI - 01 Jul 2012
Deficiency of ACE2 (angiotensin-converting enzyme 2), which degrades Ang (angiotensin) II, promotes the development of glomerular lesions. However, the mechanisms explaining why the reduction in ACE2 is associated with the development of glomerular lesions have still to be fully clarified. We hypothesized that ACE2 may regulate the renoprotective actions of ANP (atrial natriuretic peptide). The...
p32 protein levels are integral to mitochondrial and endoplasmic reticulum morphology, cell metabolism and survival
Bogoyevitch, MA; Jans, DA; Henstridge, DC; Xu, Y; Hu, M; Febbraio, MA; Boey, EJ; Ng, IH; Crawford, SA
BIOCHEM J - 01 Aug 2013
p32 [also known as HABP1 (hyaluronan-binding protein 1), gC1qR (receptor for globular head domains complement 1q) or C1qbp (complement 1q-binding protein)] has been shown previously to have both mitochondrial and non-mitochondrial localization and functions. In the present study, we show for the first time that endogenous p32 protein is a mitochondrial protein in HeLa cells under control and st...
RNA sequencing supports distinct reactive oxygen species-mediated pathways of apoptosis by high and low size mass fractions of Bay leaf (Lauris nobilis) in HT-29 cells
Lazarus, R; Rafehi, H; Khan, AW; Kerr, C; Sayakkarage, D; Ziemann, M; Karagiannis, TC; El-Osta, A; Lockett, T; Bennett, LE; Rodd, AL; Ververis, K; Loveridge, SJ
FOOD FUNCT - 01 Aug 2015
Anti-proliferative and pro-apoptotic effects of Bay leaf (Laurus nobilis) in mammalian cancer and HT-29 adenocarcinoma cells have been previously attributed to effects of polyphenolic and essential oil chemical species. Recently, we demonstrated differentiated growth-regulating effects of high (HFBL) versus low molecular mass (LFBL) aqueous fractions of bay leaf and now confirm by comparative e...
First Australian experiences with an oral volume restriction device to change eating behaviors and assist with weight loss
Hewson, ID; Jones, KM; McGee, TL; Duke, EB; Dixon, JB; Grima, MT
OBESITY - 01 Jan 2012
Eating behaviors impact satiety and caloric intake so should be considered in any weight-loss program. A novel custom-made oral device has been designed to be worn in the upper palate while eating in order to slow eating-rate and aid weight loss. The aim of this study was to assess the device's potential impact on weight-loss and gain first impressions among overweight/obese Australians. Twenty...
Projected progression of the prevalence of obesity in Australia
Shaw, JE; Backholer, K; Mannan, HR; Magliano, DJ; Walls, HL; Stevenson, CE; Peeters, A
OBESITY - 01 Apr 2012
Several country-specific and global projections of the future obesity prevalence have been conducted. However, these projections are obtained by extrapolating past prevalence of obesity or distributions of body weight. More accurate would be to base estimates on the most recent measures of weight change. Using measures of overweight and obesity incidence from a national, longitudinal study, we ...
Particle generation, functionalization and sortase A-mediated modification with targeting of single-chain antibodies for diagnostic and therapeutic use
Hagemeyer, CE; Alt, K; Johnston, AP; Peter, K; Leung, MK; Ta, HT; Such, AP; Wang, X; Prabhu, S; Caruso, F
NAT PROTOC - 01 Jan 2015
Antibody fusion to nonprotein materials such as contrast agents or radio-tracers, nano- or microparticles or small-molecule drugs is attracting major interest for molecular imaging and drug delivery. Nondirected bioconjugation techniques may impair antibody affinity, result in lower amounts of functional antibodies and generate multicomponent mixtures. We present a detailed protocol for the enz...
Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy
Edelstein, D; Schnölzer, M; Elvert, R; Konrade, I; Pirags, V; Stoyanov, S; Reeh, PW; Forbes, J; Mier, W; Stern, DM; Nau, C; Neacsu, C; Sauer, SK; Thornalley, PJ; Babes, A; Lukic, IK; Cooper, ME; Neuhuber, WL; Ziegler, D; Kichko, TI; Nawroth, PP; Haberkorn, U; Humpert, PM; Bierhaus, A; Leffler, A; Rabbani, N; Morcos, M; Brownlee, M; Schwaninger, M; Eberhardt, M; Fleming, T; Lasitschka, F; Dehmer, T
NAT MED - 01 Jun 2012
This study establishes a mechanism for metabolic hyperalgesia based on the glycolytic metabolite methylglyoxal. We found that concentrations of plasma methylglyoxal above 600 nM discriminate between diabetes-affected individuals with pain and those without pain. Methylglyoxal depolarizes sensory neurons and induces post-translational modifications of the voltage-gated sodium channel Na(v)1.8, w...
Show more...